Letters Cardiovascular outcomes with clarithromycin

Editorialists’ reply to Blake

BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i1345 (Published 08 March 2016) Cite this as: BMJ 2016;352:i1345
  1. Geetha Iyer, graduate student1,
  2. G Caleb Alexander, associate professor1
  1. 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  1. giyer1{at}jhmi.edu

Blake reminds readers that, in one of their investigations, Wong and colleagues used a Helicobacter pylori eradication regimen consisting of three products as their exposure of interest.1 2 3 We are not aware of evidence indicating that the …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe